📰 Solid Biosciences Inc News
Page 2 - Solid Biosciences Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Solid Biosciences Inc. Real-time updates on events, politics, business and more.
February 18, 2024
A beneficial owner stepped up and took a controlling stake in a struggling retailer, while public offerings of stock prompted insider buying at some biotech companies.
February 15, 2024
As of Feb. 15, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in t...
February 11, 2024
Immunovant (NASDAQ:IMVT – Get Free Report) and Solid Biosciences (NASDAQ:SLDB – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, profitability, risk, dividends, earnings and analyst recommendations. Analyst Ratings This is a summary of current ratings […]
February 4, 2024
Solid Biosciences (NASDAQ:SLDB – Get Free Report) and Immunovant (NASDAQ:IMVT – Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, dividends, valuation, earnings and profitability. Profitability This table compares Solid Biosciences and Immunovant’s net […]
January 31, 2024
Shares of Advanced Micro Devices, Inc. (NASDAQ: AMD) shares declined 3.8% to $165.49 following fourth-quarter results. AMD reported fourth-quarter non-GAAP earnings per share of 77 cents per share on revenue of $6.17 billion. AMD shares dipped 3.8% to $165.49 on Wednesday.
January 16, 2024
Although U.S. stocks closed mixed on Friday, there were a few notable insider trades.
January 16, 2024
(RTTNews) - Solid Biosciences Inc. (SLDB) on Tuesday, announced that the FDA has granted Orphan Drug Designation (ODD) for its next-generation Duc...
January 12, 2024
Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) CFO Kevin Tan sold 3,935 shares of the company’s stock in a transaction on Tuesday, January 9th. The stock was sold at an average price of $8.20, for a total value of $32,267.00. Following the sale, the chief financial officer now directly owns 9,308 shares in the […]
January 12, 2024
/PRNewswire/ -- DelveInsights Gene Therapy Market Insights report provides the current and forecast market analysis, individual leading gene therapy...
January 8, 2024
CHARLESTOWN, Mass., Jan. 08, 2024 -- Solid Biosciences Inc. , a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced that it has...